CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Clinical Oncology

• Publication date

  2007-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2006.10.2392PMID 17971586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.

  2007cited by this paper
• Post‐transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities

  2006cited by this paper
• Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study.

  2006cited by this paper
• Burkitt's lymphoma: clinicopathologic features and differential diagnosis.

  2006cited by this paper
• Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients

  2006cited by this paper
• PTLD Visualization by FDG‐PET: Improved Detection of Extranodal Localizations

  2006cited by this paper
• Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.

  2005cited by this paper
• FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation

  2005cited by this paper
• Differences between Early and Late Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Patients: Are They Two Different Diseases?

  2005cited by this paper
• Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.

  2005cited by this paper
• Posttransplant lymphoproliferative disorder: significance of central nervous system involvement.

  2005cited by this paper
• Posttransplant Lymphoproliferative Disorders after Renal Transplantation in the United States in Era of Modern Immunosuppression

  2005cited by this paper
• Analysis of Factors that Influence Survival with Post‐Transplant Lymphoproliferative Disorder in Renal Transplant Recipients: The Israel Penn International Transplant Tumor Registry Experience

  2005cited by this paper
• Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)

  2004cited by this paper
• Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas.

  2003cited by this paper
• Limitations of EBV–PCR monitoring to detect EBV associated post‐transplant lymphoproliferative disorder

  2003cited by this paper
• Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.

  2003cited by this paper
• Epstein–Barr virus‐related lymphoproliferation in children after liver transplant: Role of immunity, diagnosis, and management

  2002cited by this paper
• Anti-CD20 Monoclonal Antibody (Rituximab) Treatment for Epstein-Barr Virus-associated, B-cell Lymphoproliferative Disease in Pediatric Liver Transplant Recipients

  2002cited by this paper
• Long‐term outcome after liver transplantation in children

  2002cited by this paper
• Clinicopathologic characteristics of post-transplant lymphoproliferative disorders.

  2002cited by this paper
• Immunodeficiency‐related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry

  2002cited by this paper
• Mycophenolate, tacrolimus and post‐transplant lymphoproliferative disorder: A report of the North American Pediatric Renal Transplant Cooperative Study

  2002cited by this paper
• Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease1

  2002cited by this paper
• Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases.

  2001cited by this paper
• Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

  2001cited by this paper
• Epstein–Barr virus‐related post‐transplant lymphoproliferative disease in solid organ transplant recipients, 1988–97: A Canadian multi‐centre experience

  2001cited by this paper
• PATIENTS AT RISK FOR DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: PLASMA VERSUS PERIPHERAL BLOOD MONONUCLEAR CELLS AS MATERIAL FOR QUANTIFICATION OF EPSTEIN-BARR VIRAL LOAD BY USING REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION1,2

  2001cited by this paper
• Organ transplant-related lymphoma

  2001cited by this paper
• Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus.

  2000cited by this paper
• The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.

  2000cited by this paper
• Epstein-Barr virus infection.

  2000cited by this paper
• Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation.

  2000cited by this paper
• Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.

  2000cited by this paper
• Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.

  2000cited by this paper
• Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.

  1998cited by this paper
• Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants.

  1998cited by this paper
• Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.

  1997cited by this paper
• Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.

  1997cited by this paper
• Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms

  1995cited by this paper
• An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.

  1995cited by this paper
• Post‐transplant lymphoproliferative disorders with genetic abnormalities commonly found in malignant tumours

  1995cited by this paper
• THE FREQUENCY OF EPSTEIN‐BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN

  1988cited by this paper
• Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

  1984cited by this paper

• Non-DLBCL monomorphic and Hodgkin lymphoma PTLD: clinical insights and treatment strategies

  2025cites this paper
• Outcomes and Prognostic Assessment of Post-Transplant Lymphoproliferative Disorder: 20-Year Experience

  2025influential citation
• Post‐Liver Transplantation–Burkitt Lymphoma in Children: A Single‐Center Study of Clinical Characteristics, Treatment, and Outcomes

  2025cites this paper
• A response of rituximab plus lenalidomide therapy in patients with post-transplant lymphoproliferative disease and methotrexate-related lymphoproliferative disorder in the central nervous system: a case report

  2025cites this paper
• The IPTA Nashville consensus conference on post‐transplant lymphoproliferative disorders after solid organ transplantation in children: IV‐consensus guidelines for the management of post‐transplant lymphoproliferative disorders in children and adolescents

  2024cites this paper
• Dedicated diagnostic approaches for mature B‐cell non‐Hodgkin lymphomas occurring in children, adolescents, and young adults

  2024cites this paper
• Age and Epstein-Barr viral load at diagnosis of post-transplant lymphoproliferative disease are associated with patient survival in kidney transplant recipients

  2024cites this paper
• EBV and post-transplant lymphoproliferative disorder: a complex relationship.

  2024cites this paper
• How I Treat Post-Transplant Lymphoproliferative Disorder.

  2023cites this paper
• Evolving beyond morphology in pediatric PTLD.

  2023cites this paper
• Post-transplant lymphoproliferative disease after pediatric kidney transplant

  2022cites this paper
• Primary central nervous system lymphoma post kidney transplantation: a case report

  2022cites this paper
• Multicenter study of pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorders

  2022influential citation
• Post-transplant Lymphoproliferative Disease

  2021cites this paper
• Post-transplant Medication Challenges

  2021cites this paper
• Identification of Peripheral Blood Cells Infected with Epstein–Barr Virus: A Practical Method for Choosing the Initial Treatment for Post-Transplantation Lymphoproliferative Disease

  2021cites this paper
• Post-transplant Recipient Infectious Challenges

  2021cites this paper
• Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment

  2021cites this paper
• Complete remission from post-heart transplant lymphoproliferative disorder: A case report.

  2021cites this paper
• Epstein-Barr virus and posttransplant lymphoproliferative disorder

  2021cites this paper
• Facial Paralysis From Post-Transplant Lymphoproliferative Disorder.

  2021cites this paper
• Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders–diffuse large B-cell lymphoma

  2021cites this paper
• Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder

  2021cites this paper
• Characteristics, management, and outcome of pediatric patients with post‐transplant lymphoproliferative disease—A 20 years' experience from Austria

  2021cites this paper
• Primary post‐transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients

  2021cites this paper
• Management of PTLD after SOT

  2021cites this paper
• Prognostic Factors of PTLD after SOT

  2021cites this paper
• Neurological Complications

  2021cites this paper
• Successful treatment of CNS involvement in a patient with widely disseminated PTLD through the addition of intrathecal methotrexate to standard therapy

  2021cites this paper
• Non-Hodgkin lymphoma after pediatric kidney transplantation

  2021cites this paper
• avevmode {\color {jccasehdclr}Complete remission from post-heart transplant lymphoproliferative disorder: A case report}

  2021cites this paper
• Stereotactic Radiotherapy for Recurrent Post-Transplant Primary Central Nervous System Lymphoma

  2021cites this paper
• Post Transplant Lymphoproliferative Disorder risk factors in children: Analysis of a 23‐year single‐institutional experience

  2020cites this paper
• Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches.

  2020cites this paper
• EBV Infection and Human Primary Immune Deficiencies

  2020cites this paper
• Trisomy 3, a sole recurrent cytogenetic abnormality in pediatric polymorphic post-transplant lymphoproliferative disorder (PTLD).

  2020cites this paper
• Post‐transplant lymphoproliferative disorder after paediatric liver transplantation

  2020cites this paper
• Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan.

  2019cites this paper
• Epstein‐Barr virus infections are strongly dependent on activating and inhibitory KIR‐HLA pairs after T‐cell replate unrelated hematopoietic stem cell transplantation, the principles, and method of pairing analysis

  2019cites this paper
• Positron-emission Tomography/Computed Tomography Staging and Evaluation of Post-transplant Lymphoproliferative Disorder after Paediatric Liver Transplant: a Case Report

  2019cites this paper
• Late-Onset Central Nervous System Posttransplant Lymphoproliferative Disorder After Lung Transplantation:A Case Report.

  2019cites this paper
• Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper
• Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities

  2019cites this paper
• Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease

  2019cites this paper
• Various initial presentations of Epstein‐Barr virus infection‐associated post‐transplant lymphoproliferative disorder in pediatric liver transplantation recipients: Case series and literature review

  2019cites this paper
• Transplantationsassoziierte lymphoproliferative Erkrankungen (PTLD) bei Kindern

  2018cites this paper
• 208 – Epstein-Barr Virus (Mononucleosis and Lymphoproliferative Disorders)

  2018cites this paper
• Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease

  2018cites this paper
• Systematic review and meta‐analysis of post‐transplant lymphoproliferative disorder in lung transplant recipients

  2018cites this paper
• Epstein–Barr Virus+ Smooth Muscle Tumors as Manifestation of Primary Immunodeficiency Disorders

  2018cites this paper
• Atlas of Bone Marrow Pathology

  2018cites this paper
• Immunodeficiency-Associated Lymphoproliferative Disorder

  2018cites this paper
• Treatment of Epstein–Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusion

  2018cites this paper
• Immunotherapy with the trifunctional anti-CD20 × anti-CD3 antibody FBTA05 in a patient with relapsed t(8;14)-positive post-transplant lymphoproliferative disease

  2017cites this paper
• Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules

  2017cites this paper
• Post-transplant lymphoproliferative disorder after solid-organ transplant in children.

  2017cites this paper
• Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients

  2017cites this paper
• B-cell posttransplant lymphoproliferative disorder isolated to the central nervous system is Epstein-Barr virus positive and lacks p53 and Myc expression by immunohistochemistry.

  2017cites this paper
• Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes

  2017cites this paper
• Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level

  2017cites this paper
• Epstein–Barr Virus Infection and Lymphoproliferative Disorders After Transplantation

  2016cites this paper
• Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.

  2016cites this paper
• Post-transplant lymphoproliferative disorders

  2016cites this paper
• High incidence of Epstein–Barr virus (EBV)‐positive Hodgkin lymphoma and Hodgkin lymphoma‐like B‐cell lymphoproliferations with EBV latency profile 2 in children with interleukin‐2‐inducible T‐cell kinase deficiency

  2015cites this paper
• Dose‐level response rates of mTOR inhibition in tuberous sclerosis complex related subependymal giant cell astrocytoma

  2015cites this paper
• Post-transplant lymphoproliferative disorders.

  2015cites this paper
• Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.

  2015cites this paper
• Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage

  2015cites this paper
• The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

  2015cites this paper
• Primary Central Nervous System Posttransplant Lymphoproliferative Disease in a Bilateral Transfemoral Lower Extremity Transplantation Recipient

  2015cites this paper
• CD30 in pediatric post-transplant lymphoproliferative disease after solid organ transplant: characterization of a new therapeutic target

  2015cites this paper
• Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments.

  2014cites this paper
• Tissue‐resident T cells, in situ immunity and transplantation

  2014cites this paper
• Malignancies after pediatric kidney transplantation: more than PTLD?

  2014influential citation
• Successful treatment of systemic and central nervous system post‐transplant lymphoproliferative disorder without the use of high‐dose methotrexate or radiation

  2014cites this paper
• 96. Post-Transplant Lymphoproliferative Disorders

  2014cites this paper
• Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era

  2013cites this paper
• Post-Transplant Lymphoproliferative Disease in Pediatric Solid Organ Transplant Recipients

  2013cites this paper
• Neoplastic Diseases of the Central Nervous System

  2013cites this paper
• Posttransplant lymphoproliferative disorder in an 11-year-old immunosuppressed boy.

  2013cites this paper
• Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate

  2013cites this paper
• Validation of prognostic scores in post-transplantation lymphoproliferative disorders.

  2013cites this paper
• DNA Viral Infections Complicating Lung Transplantation

  2013cites this paper
• Trattamento della PTLD tipo linfoma di Hodgkin con chemioterapia a dosaggio ridotto e linfociti T citotossici EBV-specifici in un ricevente pediatrico di trapianto cardiaco

  2013cites this paper
• Posttransplant Lymphoproliferative Disorder in Pediatric Patients

  2013cites this paper
• Risk Factors and Prognosis in T-Cell Posttransplantation Lymphoproliferative Diseases: Reevaluation of 163 Cases

  2013influential citation
• Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies

  2013cites this paper
• Characteristics of Early and Late PTLD Development in Pediatric Solid Organ Transplant Recipients

  2013cites this paper
• Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation

  2013cites this paper
• Successful treatment of a classic Hodgkin lymphoma‐type post‐transplant lymphoproliferative disorder with tailored chemotherapy and Epstein–Barr virus‐specific cytotoxic T lymphocytes in a pediatric heart transplant recipient

  2013cites this paper
• Burden of de novo malignancy in the liver transplant recipient

  2012cites this paper
• Post Transplant Lymphoproliferative Disorders After Liver Transplantation

  2012cites this paper
• Herpesvirus-Associated Central Nervous System Diseases after Allogeneic Hematopoietic Stem Cell Transplantation

  2012cites this paper
• State of pediatric kidney transplantation in 2011.

  2012cites this paper
• Post‐transplantation lymphoproliferative disorder in pediatric kidney‐transplant recipients – A national study

  2012cites this paper
• Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey.

  2012cites this paper
• Post Transplant Lymphoproliferative Disorders: Risk, Classification, and Therapeutic Recommendations

  2012cites this paper
• Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post‐transplant lymphoproliferative disorder after kidney transplantation

  2012cites this paper
• Molecular and Clinicopathological Analysis of Epstein‐Barr Virus–Associated Posttransplant Smooth Muscle Tumors

  2012cites this paper
• CXCL13 as a Novel Marker for Diagnosis and Disease Monitoring in Pediatric PTLD

  2012cites this paper